CD4 and tuberculosis: Within this cohort, which had a baseline INH monoresistance of 6.1% (low-level resistance associated with inhA) and a significant proportion with advanced immunosuppression (25% with HIV-1 and tuberculosis and a CD4+ T-cell count of <100 cells/mm3), the estimated incidence of ADR was 0.3%–1%.